argenx SEARGXNASDAQ

Loading chart...

Want to monitor ARGX?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

Argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer.

Professional, Scientific, and Technical Services

Research and Development in Biotechnology (except Nanobiotechnology)

Tim Van Hauwermeiren

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance

Alerts

Key Statistics

About

News

TRX Gold Corporation (TRX:CA) Q1 2026 Earnings Call Transcript

ARDT INVESTOR ALERT: Ardent Health, Inc. Investors with Substantial Losses Have Opportunity to Lead the Ardent Health Class Action Lawsuit

Shareholders who lost money in shares of Ardent, Inc. (NYSE: ARDT) Should Contact Wolf Haldenstein Immediately

McFarlane Lake to Attend Vancouver Resource Investment Conference and Announces Engagements of Market Link and Emerging Markets Consulting

Boise Cascade Announces Executive Leadership Promotions

AMCON Distributing Company Reports Results for the Quarter Ended December 31, 2025

Shareholders who lost money in shares Charming Medical Ltd. (NASDAQ: MCTA) Should Contact Wolf Haldenstein Immediately

Coherent Expands Thermal Management Portfolio with High-Performance Bondable Diamond Solutions

Shareholders who lost money in shares of Jayud Global Logistics Limited (NASDAQ : JYD) Should Contact Wolf Haldenstein Immediately

Jeff Muhlenkamp's Unsung Stock Picks Outside AI & Gold Bull Case

Quantum Enablers Set for 2026 Breakout: AMD, AVGO, TER in Focus

Trump Is Set to Unveil Big Plans Addressing Housing Affordability This Week. Here's What We Know

EPAM Announces Date for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

Bitzero Holdings Inc. Acquires NVIDIA Blackwell B300 GPU Servers to Launch AI Compute Pilot with Hydra Host

America's Largest Home Builder Reports Earnings Tuesday. Policy Takes Priority.

Royal Caribbean poised for modest Q4 beat, Jefferies sees choppier water ahead

Prediction: This Healthcare Stock Could Soar by 72% in 2026

FRMI INVESTOR NOTICE: Fermi Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

WENDEL : Déclaration

WENDEL: Statement